Keith Haring Tone Blur Essence Sunscreen

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 84326-324
  • Package NDC 84326-324-02
  • Application number M020
  • SPL ID 41a6e80c-8a18-7af4-e063-6394a90ab33f
  • SPL set ID 1d578196-c785-9914-e063-6394a90a0533
  • UNII G63QQF2NOX
  • UNII V06SV4M95S
  • UNII 5A68WGF6WM
  • UNII 4X49Y0596W

What the source publishes

Labeler
RBGROUP Co., Ltd
Active ingredients
Homosalate, Octocrylene, Octisalate, Avobenzone
Form
CREAM
Routes
TOPICAL
Administrative status
present-in-source-snapshot
Marketing status
OTC MONOGRAPH DRUG
Product type
HUMAN OTC DRUG
Prescription
Non-prescription

Names this record is found by

Complete source data
us:fda:ndc:84326-324_41a6e80c-8a18-7af4-e063-6394a90ab33f
{
  "name": "Keith Haring Tone Blur Essence Sunscreen",
  "splId": "41a6e80c-8a18-7af4-e063-6394a90ab33f",
  "labels": [
    {
      "setId": "1d578196-c785-9914-e063-6394a90a0533",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1d578196-c785-9914-e063-6394a90a0533",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1d578196-c785-9914-e063-6394a90a0533"
    }
  ],
  "routes": [
    "TOPICAL"
  ],
  "labeler": "RBGROUP Co., Ltd",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 TUBE in 1 CARTON (84326-324-02)  / 50 mL in 1 TUBE (84326-324-01)",
      "package_ndc": "84326-324-02",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20240717"
    }
  ],
  "productId": "84326-324_41a6e80c-8a18-7af4-e063-6394a90ab33f",
  "useDomain": "unknown",
  "dosageForm": "CREAM",
  "productNdc": "84326-324",
  "deaSchedule": null,
  "genericName": "Homosalate, Octocrylene, Octisalate, Avobenzone",
  "productType": "HUMAN OTC DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "AVOBENZONE",
      "strength": "1.5 g/50mL"
    },
    {
      "name": "HOMOSALATE",
      "strength": "5 g/50mL"
    },
    {
      "name": "OCTOCRYLENE",
      "strength": "4.35 g/50mL"
    },
    {
      "name": "OCTISALATE",
      "strength": "2.5 g/50mL"
    }
  ],
  "applicationNumber": "M020",
  "marketingCategory": "OTC MONOGRAPH DRUG",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20240716",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "non-prescription",
  "harmonizedIdentifiers": {
    "unii": [
      "G63QQF2NOX",
      "V06SV4M95S",
      "5A68WGF6WM",
      "4X49Y0596W"
    ],
    "spl_set_id": [
      "1d578196-c785-9914-e063-6394a90a0533"
    ],
    "manufacturer_name": [
      "RBGROUP Co., Ltd"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:84326-324_41a6e80c-8a18-7af4-e063-6394a90ab33f"